Trametinib Shows Promise for Children with Relapsed or Refractory JMML
PHILADELPHIA – The MEK inhibitor trametinib (Mekinist) was an effective treatment for pediatric patients with relapsed or refractory juvenile...
Search/Filter
Loading...
HPV Testing for Cervical Cancer May Be Safe at Longer Intervals Than What Current Guidelines Recommend
HPV testing eight years after a negative result instead of the recommended five was found comparable to standard cytology...
Outcomes After Stem Cell Transplant in Elderly Patients With Acute Myeloid Leukemia Have Improved Since 2000
Among patients over 65 who received an allogeneic hematopoietic stem cell transplant (allo-HCT) for the treatment of acute myeloid...
AACR Names New Editor-in-Chief of the Journal Cancer Prevention Research
PHILADELPHIA – The American Association for Cancer Research (AACR) today announced the appointment of Nickolas Papadopoulos, PhD, as editor-in-chief...
FDG PET/CT Imaging After Just One Week May Predict Treatment Response in Patients With Advanced Melanoma
Following a single dose of pembrolizumab, FDG PET/CT scans were able to show metabolic changes in tumors that correlated...
Patients With Metastatic Colorectal Cancer May Continue Benefitting From Immunotherapy After Treatment Discontinuation
PHILADELPHIA – The majority of patients with metastatic colorectal cancer whose cancer did not progress during initial treatment with...
More Than 10% of Samples From a Stool-based Colorectal Cancer Test May Be Unsatisfactory
Fewer than half of patients with unsatisfactory samples from fecal immunochemical tests completed follow-up testing within 15 months PHILADELPHIA...
Nearly Half of Oncology Drugs Approved Since 1998 Are Precision Therapies
Cancer patients eligible for precision oncology therapies nearly doubled between 2017 and 2022 PHILADELPHIA – Of the 198 new...
Intravenous Immunoglobulin May Prevent Severe Infections Associated with Anti-BCMA Therapy for Multiple Myeloma
PHILADELPHIA – Intravenous immunoglobulin (IVIg) reduced the risk of severe infections by 90% in patients with multiple myeloma undergoing...
A Dendritic Cell Vaccine Was Safe and Induced Immune Responses in Patients With Multiple Myeloma
Vaccination given in combination with autologous stem cell transplant was associated with long-term disease control PHILADELPHIA – A dendritic...